Literature DB >> 23590737

Changing law from barrier to facilitator of opioid overdose prevention.

Corey Davis1, Damika Webb, Scott Burris.   

Abstract

Opioid overdose is the leading cause of accidental injury death in the United States, taking the lives of over 16,000 Americans every year. Many of those deaths are preventable through the timely provision of naloxone, a drug that reliably and effectively reverses opioid overdose. However, that drug is often not available where and when it is needed, due in large part to laws that pre-date the overdose epidemic. Preliminary evidence suggests that amending those laws to encourage the prescription and use of naloxone will reduce opioid overdose deaths, and a number of states have done so in the past several years. Since legal amendments designed to facilitate naloxone access have no documented negative effects, can be implemented at little or no cost, and have the potential to save both lives and resources, states that have not passed them may benefit from doing so.
© 2013 American Society of Law, Medicine & Ethics, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23590737     DOI: 10.1111/jlme.12035

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


  26 in total

1.  Critical opportunities for public health law: a call for action.

Authors:  Michelle M Mello; Jennifer Wood; Scott Burris; Alexander C Wagenaar; Jennifer K Ibrahim; Jeffrey W Swanson
Journal:  Am J Public Health       Date:  2013-09-12       Impact factor: 9.308

Review 2.  Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access.

Authors:  Daniel P Wermeling
Journal:  Ther Adv Drug Saf       Date:  2015-02

3.  Why are some people who have received overdose education and naloxone reticent to call Emergency Medical Services in the event of overdose?

Authors:  Stephen Koester; Shane R Mueller; Lisa Raville; Sig Langegger; Ingrid A Binswanger
Journal:  Int J Drug Policy       Date:  2017-07-19

4.  Engaging Law Enforcement in Overdose Reversal Initiatives: Authorization and Liability for Naloxone Administration.

Authors:  Corey S Davis; Derek Carr; Jessica K Southwell; Leo Beletsky
Journal:  Am J Public Health       Date:  2015-06-11       Impact factor: 9.308

5.  Law enforcement attitudes toward overdose prevention and response.

Authors:  Traci C Green; Nickolas Zaller; Wilson R Palacios; Sarah E Bowman; Madeline Ray; Robert Heimer; Patricia Case
Journal:  Drug Alcohol Depend       Date:  2013-09-02       Impact factor: 4.492

6.  Expanded access to naloxone among firefighters, police officers, and emergency medical technicians in Massachusetts.

Authors:  Corey S Davis; Sarah Ruiz; Patrick Glynn; Gerald Picariello; Alexander Y Walley
Journal:  Am J Public Health       Date:  2014-06-12       Impact factor: 9.308

7.  Overdose Epidemic, Prescription Monitoring Programs, and Public Health: A Review of State Laws.

Authors:  Corey S Davis; Jill E Johnston; Matthew W Pierce
Journal:  Am J Public Health       Date:  2015-09-17       Impact factor: 9.308

8.  Co-prescribing naloxone does not increase liability risk.

Authors:  Corey S Davis; Scott Burris; Leo Beletsky; Ingrid Binswanger
Journal:  Subst Abus       Date:  2016 Oct-Dec       Impact factor: 3.716

9.  Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program.

Authors:  Christopher Rowe; Glenn-Milo Santos; Eric Vittinghoff; Eliza Wheeler; Peter Davidson; Philip O Coffin
Journal:  Addiction       Date:  2015-08       Impact factor: 6.526

10.  Knowledge of Good Samaritan Laws and Beliefs About Arrests Among Persons Who Inject Drugs a Year After Policy Change in Baltimore, Maryland.

Authors:  Kristin E Schneider; Ju Nyeong Park; Sean T Allen; Brian W Weir; Susan G Sherman
Journal:  Public Health Rep       Date:  2020-04-07       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.